Leflunomide and Timolol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Leflunomide (leflunomide) and Timolol (timolol). Common drug interactions include cardio-respiratory arrest among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Leflunomide and Timolol. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Leflunomide?

Leflunomide has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 82,105 Leflunomide users. Check the latest studies of Leflunomide.

What is Timolol?

Timolol has active ingredients of timolol. It is often used in glaucoma. eHealthMe is studying from 9,142 Timolol users. Check the latest studies of Timolol.

On Jul, 14, 2026

34 people who take Leflunomide and Timolol together, and have interactions are studied.

Leflunomide and Timolol drug interactions.

What are the common drug interactions of Leflunomide and Timolol, by gender? *:

female:

Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Diarrhoea
Escherichia sepsis (bacterial infection by escherichia coli)
Hypertension (high blood pressure)
Renal failure (kidney dysfunction)
Laryngeal disorder (disease of larynx related to voice)
Drug ineffective
Drug intolerance (drug sensitivity)
Abdominal discomfort
Blood pressure increased

male:

Arthralgia (joint pain)
Back pain
Weight decreased
Asthenia (weakness)
Bladder disorder
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Cataract (clouding of the lens inside the eye)
Cerebrospinal fluid leakage
Dental caries
Eye haemorrhage (bleeding in the eye)

What are the common drug interactions of Leflunomide and Timolol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Intraocular pressure increased

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Hypertension (high blood pressure)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Drug intolerance (drug sensitivity)
Intervertebral disc degeneration (spinal disc degeneration)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Injection site bruising
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Psoriasis (immune-mediated disease that affects the skin)
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Abdominal discomfort

What are the existing conditions these people have? *

Polychondritis (progressive inflammation of cartilage and other connective tissue): 11 people, 32.35%
Dry Eyes (lack of adequate tears): 10 people, 29.41%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 11.76%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Leflunomide and Timolol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously